We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
Linking Healthcare and Genomics Research
Webinar

Linking Healthcare and Genomics Research

On Demand
In this webinar, Dr. Richard Scott, Chief Medical Officer at Genomics England, will talk about the benefits and challenges of utilizing genetic technologies to understand disease at the individual level, and how this research is being applied to inform patient care.
Advantages of Custom Chromatography Resin Development for the Purification of Complex Biotherapeutics
Webinar

Advantages of Custom Chromatography Resin Development for the Purification of Complex Biotherapeutics

On Demand
Advancements in biotherapeutics have initiated an increasing range of complex molecules often presenting unique purification challenges. Addressing these challenges requires novel purification strategies for commercial manufacturing, which may not always exist. When your specific process needs cannot be met with off-the-shelve resins, custom resin production may be a viable solution.
Advancing Vaccine Development With Novel Purification Strategies
Webinar

Advancing Vaccine Development With Novel Purification Strategies

On Demand
Vaccination has proven to be the most successful form of disease prevention available today. However, infectious diseases still account for large numbers of the yearly reported casualties, especially in developing countries.
How To Find Promising Small Molecule Leads
Webinar

How To Find Promising Small Molecule Leads

On Demand
Learn how scientists in the drug discovery field search for the most promising lead compounds. Dr. Claire Hatty from NanoTemper will highlight case studies demonstrating the value of biophysical tools in drug discovery workflows.
Utilizing the Gibco™ CTS™ Rotea™ System, a Versatile Closed Manufacturing System, for Cell and Gene Therapy Development
Webinar

Utilizing the Gibco™ CTS™ Rotea™ System, a Versatile Closed Manufacturing System, for Cell and Gene Therapy Development

On Demand
Cell and gene therapy involves extracting cells, protein or genetic material from a patient or donor and altering them to provide a highly personalised therapy. These therapies have shown potential to offer longer-lasting effects than traditional methods.
Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing
Webinar

Applying a Closed, Modular, Semi-Automated System to CAR T Cell Therapy Manufacturing

On Demand
Cell-based chimeric antigen receptor (CAR) T cell therapies have rapidly advanced in recent years, with a variety of targets in clinical research and several FDA approved products already on the market.
Advertisement